
    
      The purpose of this study is to measure the immune response to the COVID-19 vaccine in cancer
      patients and compare to the general population. This information can help optimize the timing
      of the mRNA-1273 vaccine relative to starting treatment for cancer, adding booster
      immunizations or incorporation of medications that to enhance the immune response.
    
  